The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS) — for reasons that might be unrelated to the drug’s intended cholesterol lowering affects, a new study has found.
Click here for original story, Statins’ potential to treat MS unrelated to lowering cholesterol
Source: ScienceDaily